OBJECTIVE: Traditional electrocortical stimulation (ECS) mapping is limited by the lengthy serial investigation (one location at a time) and the risk of afterdischarges in localizing eloquent cortex. Electrocorticographic frequency alteration mapping (EFAM) allows the parallel investigation of many cortical sites in much less time and with no risk of afterdischarges because of its passive nature. We examined its use with ECS in the context of language mapping during an awake craniotomy for a tumor resection. CLINICAL PRESENTATION: The patient was a 61-year-old right-handed Caucasian male who presented with headache and mild aphasia. Imaging demonstrated a 3-cm cystic mass in the posterior temporal-parietal lobe. The patient underwent an awake craniotomy for the mapping of his speech cortex and resection of the mass. INTERVENTION: Using a 32-contact electrode array, electrocorticographic signals were recorded from the exposed cortex as the patient participated in a 3-min screening task involving active (patient naming visually presented words) and rest (patient silent) conditions. A spectral comparison of the 2 conditions revealed specific cortical locations associated with activation during speech. The patient was then widely mapped using ECS. Three of 4 sites identified by ECS were also identified passively and in parallel by EFAM, 2 with statistical significance and the third by qualitative inspection. CONCLUSION: EFAM was technically achieved in an awake craniotomy patient and had good concordance with ECS mapping. Because it poses no risk of afterdischarges and offers substantial time savings, EFAM holds promise for future development as an adjunct intraoperative mapping tool. Additionally, the cortical signals obtained by this modality can be utilized for localization in the presence of a tumor adjacent to the eloquent regions. 2009 S. Karger AG, Basel.
OBJECTIVE: Traditional electrocortical stimulation (ECS) mapping is limited by the lengthy serial investigation (one location at a time) and the risk of afterdischarges in localizing eloquent cortex. Electrocorticographic frequency alteration mapping (EFAM) allows the parallel investigation of many cortical sites in much less time and with no risk of afterdischarges because of its passive nature. We examined its use with ECS in the context of language mapping during an awake craniotomy for a tumor resection. CLINICAL PRESENTATION: The patient was a 61-year-old right-handed Caucasian male who presented with headache and mild aphasia. Imaging demonstrated a 3-cm cystic mass in the posterior temporal-parietal lobe. The patient underwent an awake craniotomy for the mapping of his speech cortex and resection of the mass. INTERVENTION: Using a 32-contact electrode array, electrocorticographic signals were recorded from the exposed cortex as the patient participated in a 3-min screening task involving active (patient naming visually presented words) and rest (patient silent) conditions. A spectral comparison of the 2 conditions revealed specific cortical locations associated with activation during speech. The patient was then widely mapped using ECS. Three of 4 sites identified by ECS were also identified passively and in parallel by EFAM, 2 with statistical significance and the third by qualitative inspection. CONCLUSION: EFAM was technically achieved in an awake craniotomy patient and had good concordance with ECS mapping. Because it poses no risk of afterdischarges and offers substantial time savings, EFAM holds promise for future development as an adjunct intraoperative mapping tool. Additionally, the cortical signals obtained by this modality can be utilized for localization in the presence of a tumor adjacent to the eloquent regions. 2009 S. Karger AG, Basel.
Authors: Daniel M Branco; Tatiana M Coelho; Bianca M Branco; Letícia Schmidt; Maria E Calcagnotto; Mirna Portuguez; Eliseu Paglioli Neto; Eduardo Paglioli; André Palmini; José V Lima; Jaderson C Da Costa Journal: J Clin Neurophysiol Date: 2003-02 Impact factor: 2.177
Authors: Mitchell M Rohde; Spencer L BeMent; Jane E Huggins; Simon P Levine; Ramesh K Kushwaha; Lori A Schuh Journal: IEEE Trans Biomed Eng Date: 2002-01 Impact factor: 4.538
Authors: Eric C Leuthardt; Gerwin Schalk; Jonathan R Wolpaw; Jeffrey G Ojemann; Daniel W Moran Journal: J Neural Eng Date: 2004-06-14 Impact factor: 5.379
Authors: Eric C Leuthardt; Kai Miller; Nicholas R Anderson; Gerwin Schalk; Joshua Dowling; John Miller; Daniel W Moran; Jeff G Ojemann Journal: Neurosurgery Date: 2007-04 Impact factor: 4.654
Authors: G Evren Keles; David A Lundin; Kathleen R Lamborn; Edward F Chang; George Ojemann; Mitchel S Berger Journal: J Neurosurg Date: 2004-03 Impact factor: 5.115
Authors: Jonathan D Breshears; Charles M Gaona; Jarod L Roland; Mohit Sharma; David T Bundy; Joshua S Shimony; Samiya Rashid; Lawrence N Eisenman; R Edward Hogan; Abraham Z Snyder; Eric C Leuthardt Journal: Neurosurgery Date: 2012-08 Impact factor: 4.654
Authors: Jarod L Roland; Natalie Griffin; Carl D Hacker; Ananth K Vellimana; S Hassan Akbari; Joshua S Shimony; Matthew D Smyth; Eric C Leuthardt; David D Limbrick Journal: J Neurosurg Pediatr Date: 2017-09-29 Impact factor: 2.375
Authors: AmiLyn M Taplin; Adriana de Pesters; Peter Brunner; Dora Hermes; John C Dalfino; Matthew A Adamo; Anthony L Ritaccio; Gerwin Schalk Journal: Epilepsy Behav Case Rep Date: 2016-03-16